Scilex Holding Co Files 8-K on Operations
Ticker: SCLXW · Form: 8-K · Filed: Apr 16, 2024 · CIK: 1820190
| Field | Detail |
|---|---|
| Company | Scilex Holding Co (SCLXW) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50, $34.0 million, $38.0 m, $27.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, disclosure
Related Tickers: SCLX
TL;DR
Scilex filed an 8-K updating on financials and operations.
AI Summary
Scilex Holding Company filed an 8-K on April 16, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates Scilex Holding Co is providing updates on its financial status and operational results to the SEC, which is crucial for investors to assess the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of operational and financial information without immediate significant events.
Key Players & Entities
- Scilex Holding Co (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-39852 (commission_file_number) — SEC File Number
FAQ
What specific financial results are being reported by Scilex Holding Co?
The provided text indicates an 8-K filing concerning 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' but does not detail the specific financial figures within this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 16, 2024.
What is the Standard Industrial Classification for Scilex Holding Co?
The Standard Industrial Classification for Scilex Holding Co is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
What is the business address of Scilex Holding Co?
The business address of Scilex Holding Co is 960 San Antonio Road, Palo Alto, CA 94303.
Has Scilex Holding Co undergone any previous name changes?
Yes, Scilex Holding Co was formerly known as Scilex Holding Company/DE (name change on 20221117) and Vickers Vantage Corp. I (name change on 20200804).
Filing Stats: 727 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2024-04-16 16:06:08
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
- $11.50 — mon stock, each at an exercise price of $11.50 per share SCLXW The Nasdaq Stock Ma
- $34.0 million — st quarter of 2024 were in the range of $34.0 million to $38.0 million, compared to $27.5 mil
- $38.0 m — 4 were in the range of $34.0 million to $38.0 million, compared to $27.5 million for th
- $27.5 million — 0 million to $38.0 million, compared to $27.5 million for the first quarter of 2023, represen
- $12.0 million — st quarter of 2024 were in the range of $12.0 million to $13.0 million, compared to $10.6 mil
- $13.0 m — 4 were in the range of $12.0 million to $13.0 million, compared to $10.6 million for th
- $10.6 million — 0 million to $13.0 million, compared to $10.6 million for the first quarter of 2023, represen
Filing Documents
- d815788d8k.htm (8-K) — 28KB
- d815788dex991.htm (EX-99.1) — 18KB
- g815788g0416215546205.jpg (GRAPHIC) — 5KB
- g815788g0416215546479.jpg (GRAPHIC) — 1KB
- g815788g0416215546670.jpg (GRAPHIC) — 1KB
- g815788g0416215546865.jpg (GRAPHIC) — 1KB
- 0001193125-24-097730.txt ( ) — 224KB
- sclx-20240416.xsd (EX-101.SCH) — 4KB
- sclx-20240416_def.xml (EX-101.DEF) — 14KB
- sclx-20240416_lab.xml (EX-101.LAB) — 23KB
- sclx-20240416_pre.xml (EX-101.PRE) — 14KB
- d815788d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated April 16, 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Jaisim Shah Name: Jaisim Shah Title: Chief Executive Officer & President Date: April 16, 2024 3